SCM
Superstring Capital Management Portfolio holdings
AUM
$80.3M
This Quarter Return
+1.98%
1 Year Return
+68.23%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$83.8M
AUM Growth
+$83.8M
(-26%)
Cap. Flow
-$22.3M
Cap. Flow
% of AUM
-26.59%
Top 10 Holdings %
Top 10 Hldgs %
66.17%
Holding
52
New
13
Increased
7
Reduced
9
Closed
18
Top Buys
| 1 |
VRNA
Verona Pharma
VRNA
|
$6.15M |
| 2 |
Pfizer
PFE
|
$4.97M |
| 3 |
Travere Therapeutics
TVTX
|
$4.26M |
| 4 |
Legend Biotech
LEGN
|
$3.08M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$2.39M |
Top Sells
| 1 |
NovoCure
NVCR
|
$8.55M |
| 2 |
Structure Therapeutics
GPCR
|
$5.88M |
| 3 |
IDEAYA Biosciences
IDYA
|
$5.84M |
| 4 |
Oric Pharmaceuticals
ORIC
|
$4.25M |
| 5 |
Zai Lab
ZLAB
|
$3.93M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Avidity Biosciences
RNA
$6.12B
| $657K | 0.78% |
+22,271
| New | +$657K |
|
27
Cabaletta Bio
CABA
$144M
| $636K | 0.76% |
458,972
-363,321
| -44% | -$503K |
|
28
Vaxcyte
PCVX
$4.17B
| $425K | 0.51% |
+11,264
| New | +$425K |
|
29
Kyverna Therapeutics
KYTX
$161M
| $369K | 0.44% |
191,287
+9,110
| +5% | +$17.6K |
|
30
Ocular Therapeutix
OCUL
$2.25B
| $310K | 0.37% |
+42,297
| New | +$310K |
|
31
Schrodinger
SDGR
$1.42B
| $279K | 0.33% |
+14,114
| New | +$279K |
|
32
Century Therapeutics
IPSC
$40.4M
| $220K | 0.26% |
462,963
| – | – |
|
|
LSB
33
LakeShore Biopharma
LSB
$34.9M
| $74.5K | 0.09% |
30,792
| – | – |
|
34
EyePoint Pharmaceuticals
EYPT
$827M
| – | – |
-49,375
| Closed | -$368K |
|
35
Fate Therapeutics
FATE
$115M
| – | – |
-1,379,556
| Closed | -$2.28M |
|
|
36
Structure Therapeutics
GPCR
$1.14B
| – | – |
-216,811
| Closed | -$5.88M |
|
|
37
IDEAYA Biosciences
IDYA
$2.26B
| – | – |
-227,102
| Closed | -$5.84M |
|
38
Incyte
INCY
$17B
| – | – |
-18,009
| Closed | -$1.24M |
|
39
Insmed
INSM
$30.3B
| – | – |
-35,966
| Closed | -$2.48M |
|
40
Kura Oncology
KURA
$732M
| – | – |
-157,959
| Closed | -$1.38M |
|
41
Lexeo Therapeutics
LXEO
$266M
| – | – |
-52,616
| Closed | -$346K |
|
|
42
NovoCure
NVCR
$1.35B
| – | – |
-286,970
| Closed | -$8.55M |
|
43
Protagonist Therapeutics
PTGX
$3.62B
| – | – |
-68,892
| Closed | -$2.66M |
|
44
Rezolute
RZLT
$630M
| – | – |
-123,184
| Closed | -$604K |
|
45
Instil Bio
TIL
$196M
| – | – |
-148,017
| Closed | -$2.83M |
|
46
Tango Therapeutics
TNGX
$745M
| – | – |
-474,955
| Closed | -$1.47M |
|
47
Zura Bio
ZURA
$132M
| – | – |
-186,943
| Closed | -$467K |
|
|
CLYM
48
Climb Bio, Inc. Common Stock
CLYM
$165M
| – | – |
-98,160
| Closed | -$177K |
|
|
ONC
49
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| – | – |
-6,365
| Closed | -$1.18M |
|
50
Axsome Therapeutics
AXSM
$6.09B
| – | – |
-4,268
| Closed | -$361K |
|